Danaher Corporation (NYSE:DHR) Shares Purchased by United Super Pty Ltd in its capacity as Trustee for the Construction & Building Unions Superannuation Fund

Key Points

• United Super Pty Ltd increased its stake in Danaher Corporation by 26.8% during the 1st quarter, owning 94,786 shares valued at $19.4 million.
• Institutional investors control 79.05% of Danaher's stock, with several firms, including OVERSEA CHINESE BANKING Corp Ltd, making significant increases to their holdings in the same period.
• Danaher recently reported an EPS of $1.80, exceeding the consensus estimate, and declared a quarterly dividend of $0.32 per share.

United Super Pty Ltd in its capacity as Trustee for the Construction & Building Unions Superannuation Fund lifted its holdings in shares of Danaher Corporation (NYSE:DHR - Free Report) by 26.8% during the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 94,786 shares of the conglomerate's stock after acquiring an additional 20,039 shares during the quarter. United Super Pty Ltd in its capacity as Trustee for the Construction & Building Unions Superannuation Fund's holdings in Danaher were worth $19,431,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors have also recently added to or reduced their stakes in DHR. GHP Investment Advisors Inc. lifted its stake in shares of Danaher by 396.0% during the first quarter. GHP Investment Advisors Inc. now owns 124 shares of the conglomerate's stock worth $25,000 after purchasing an additional 99 shares in the last quarter. Heck Capital Advisors LLC purchased a new position in Danaher in the 4th quarter worth approximately $27,000. Sierra Ocean LLC raised its stake in shares of Danaher by 116.9% during the first quarter. Sierra Ocean LLC now owns 141 shares of the conglomerate's stock valued at $29,000 after purchasing an additional 76 shares during the period. Smallwood Wealth Investment Management LLC acquired a new position in shares of Danaher during the first quarter worth $31,000. Finally, Hurley Capital LLC purchased a new position in shares of Danaher in the fourth quarter valued at $34,000. 79.05% of the stock is owned by hedge funds and other institutional investors.

Danaher Stock Performance

Shares of NYSE:DHR traded up $1.69 during trading hours on Tuesday, hitting $199.15. The stock had a trading volume of 4,001,120 shares, compared to its average volume of 4,305,692. The stock's fifty day simple moving average is $197.75 and its 200 day simple moving average is $201.87. The firm has a market capitalization of $142.60 billion, a price-to-earnings ratio of 42.37, a PEG ratio of 2.74 and a beta of 0.73. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.22 and a current ratio of 1.62. Danaher Corporation has a 1-year low of $171.00 and a 1-year high of $279.90.

Danaher (NYSE:DHR - Get Free Report) last announced its earnings results on Tuesday, July 22nd. The conglomerate reported $1.80 earnings per share for the quarter, beating the consensus estimate of $1.64 by $0.16. Danaher had a return on equity of 10.70% and a net margin of 14.21%. The firm had revenue of $5.94 billion for the quarter, compared to the consensus estimate of $5.83 billion. During the same quarter in the previous year, the business earned $1.72 EPS. The firm's revenue for the quarter was up 3.4% on a year-over-year basis. Sell-side analysts anticipate that Danaher Corporation will post 7.63 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

A number of equities analysts have commented on the stock. Barclays reiterated an "overweight" rating and issued a $225.00 price objective (up previously from $215.00) on shares of Danaher in a report on Tuesday, June 24th. Robert W. Baird increased their price target on Danaher from $225.00 to $226.00 and gave the company an "outperform" rating in a report on Friday, July 18th. Evercore ISI dropped their price objective on Danaher from $230.00 to $226.00 and set an "outperform" rating on the stock in a report on Tuesday, July 8th. The Goldman Sachs Group reduced their target price on Danaher from $260.00 to $240.00 and set a "neutral" rating for the company in a research note on Wednesday, April 23rd. Finally, Argus dropped their price target on shares of Danaher from $260.00 to $240.00 in a research note on Wednesday, April 23rd. Three equities research analysts have rated the stock with a hold rating and eighteen have issued a buy rating to the company's stock. According to MarketBeat.com, the company currently has an average rating of "Moderate Buy" and a consensus target price of $247.61.

Insiders Place Their Bets

In other news, Chairman Steven M. Rales sold 1,250,000 shares of the stock in a transaction that occurred on Monday, May 12th. The shares were sold at an average price of $196.74, for a total value of $245,925,000.00. Following the completion of the transaction, the chairman directly owned 3,105,808 shares in the company, valued at $611,036,665.92. This trade represents a 28.70% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. 11.20% of the stock is owned by insiders.

Danaher Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.